DBV Technologies SA (DBVT)
0.78
+0.02
(+2.47%)
USD |
NASDAQ |
Nov 04, 16:00
0.7831
0.00 (0.00%)
After-Hours: 20:00
DBV Technologies Total Liabilities (Quarterly): 35.10M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 35.10M |
| March 31, 2024 | 34.24M |
| December 31, 2023 | 42.80M |
| September 30, 2023 | 45.79M |
| June 30, 2023 | 53.28M |
| March 31, 2023 | 53.84M |
| December 31, 2022 | 52.06M |
| September 30, 2022 | 36.06M |
| June 30, 2022 | 40.56M |
| March 31, 2022 | 35.52M |
| December 31, 2021 | 47.45M |
| September 30, 2021 | 54.03M |
| June 30, 2021 | 57.56M |
| March 31, 2021 | 52.23M |
| December 31, 2020 | 66.76M |
| June 30, 2020 | 84.81M |
| December 31, 2019 | 78.54M |
| September 30, 2019 | 74.89M |
| June 30, 2019 | 79.97M |
| June 30, 2019 | 79.97M |
| December 31, 2018 | 57.72M |
| Date | Value |
|---|---|
| June 30, 2018 | 52.43M |
| June 30, 2018 | 52.43M |
| December 31, 2017 | 57.45M |
| June 30, 2017 | 52.88M |
| June 30, 2017 | 52.88M |
| December 31, 2016 | 46.96M |
| June 30, 2016 | 41.79M |
| June 30, 2016 | 41.79M |
| December 31, 2015 | 23.18M |
| June 30, 2015 | 14.99M |
| June 30, 2015 | 14.99M |
| December 31, 2014 | 12.12M |
| June 30, 2014 | 9.888M |
| June 30, 2014 | 9.888M |
| December 31, 2013 | 8.066M |
| June 30, 2013 | 6.914M |
| June 30, 2013 | 6.914M |
| December 31, 2012 | 5.028M |
| June 30, 2012 | 3.300M |
| December 31, 2011 | 5.203M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
34.24M
Minimum
Mar 2024
84.81M
Maximum
Jun 2020
51.21M
Average
52.06M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| Edap TMS SA | 37.01M |
| Genfit SA | 117.09M |
| Cellectis SA | 258.54M |
| Adaptimmune Therapeutics PLC | 225.43M |
| Akari Therapeutics PLC | 8.779M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 114.19M |
| Shareholders Equity (Quarterly) | 79.10M |